未登录

Z

Zhenyu Ding

Sichuan University

H指数:25

被引数:6,038

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant nedaplatin and paclitaxel regimen with concurrent radiotherapy for esophageal squamous cell carcinoma: a single-arm phase II clinical trial

新辅助奈达铂和紫杉醇方案联合同期放疗治疗食管鳞状细胞癌：一项单臂II期临床试验

Future Oncology

IF2.6

2026-07-140

OA

A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial

一种新型抗结核药物具有强大的临床疗效和良好的安全性: 一项开放标签，随机对照，多中心2a期试验

Signal Transduction and Targeted Therapy

IF52.7

2025-12-300

OAAI

Safety, Tolerability, and Pharmacokinetics of a Novel Nitroimidazooxazole Antitubercular Agent in Healthy Adults: A Phase I Trial

安全性、耐受性及药代动力学：一种新型硝基咪唑恶唑烷抗结核药物在健康成年人的I期临床试验

IF10.7

2025-12-040

OAAI

Zoning Method for Groundwater Pollution Risk Control in Typical Industrial–Urban Integration Areas in the Middle Reaches of the Yangtze River

长江中游典型工城融合区地下水污染风险控制分区方法

IF0

2025-08-080

OA

Prospects and Challenges of Lung Cancer Vaccines

肺癌疫苗的前景与挑战

IF0

2025-08-060

OA

A dendritic cell vaccine for both vaccination and neoantigen-reactive T cell preparation for cancer immunotherapy in mice

NATURE COMMUNICATIONS

IF15.7

2024-11-290

OAAI

Prognostic factors and prognostic model of non-metastatic clear cell renal cell carcinoma

非转移性肾透明细胞癌的预后因素及预后模型

IF3.4

2024-10-100

OAAI

Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial

BRITISH JOURNAL OF CANCER

IF6.8

2024-08-201

OA

Development and Clinical Applications of Therapeutic Cancer Vaccines with Individualized and Shared Neoantigens

个体化和共享新抗原的治疗性癌症疫苗的开发和临床应用

IF3.4

2024-06-271

OAAI

Safety and feasibility of personalized neoantigen DC vaccines in postoperative esophagus squamous cell carcinoma: A Phase 1b trial

CANCER RESEARCH

IF16.6

2024-03-221

PRE

Neoadjuvant nedaplatin and paclitaxel regimen with concurrent radiotherapy for esophageal squamous cell carcinoma: A single-arm phase II clinical trial

ANNALS OF ONCOLOGY

IF65.4

2023-06-010

OA

Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer

SCIENTIFIC REPORTS

IF3.9

2022-12-2618

OAAI

Evaluation of the nutritional index and immunological function of a fermented vegetable for esophageal cancer patients undergoing immunotherapy plus chemotherapy: A randomized controlled trial

JOURNAL OF FUNCTIONAL FOODS

IF4

2022-12-010

PRE

Editorial: The Clinical Application of Neoantigens

社论: 新抗原的临床应用

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-03-030

OAAI

Viral infections and the efficacy of PD-(L)1 inhibitors in virus-related cancers: Head and neck squamous cell carcinoma and hepatocellular carcinoma

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2021-11-0119

OAAI

Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors

JOURNAL OF BONE ONCOLOGY

IF3.5

2021-08-018

OAAI

Toxicities of Immunotherapy for Small Cell Lung Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2021-05-318

OAAI

Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment

CELL PROLIFERATION

IF5.6

2021-03-02108

OAAI

Thyroid function abnormality induced by PD-1 inhibitors have a positive impact on survival in patients with non-small cell lung cancer

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2021-02-0126

PREAI

The Ways of Isolating Neoantigen-Specific T Cells

新抗原特异性T细胞的分离方法

FRONTIERS IN ONCOLOGY

IF3.3

2020-08-1127

OAAI